GSK plc
SEC-identified person · CIK 1131399 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Wave Life Sciences Ltd. WVE | Officer | filed 2023 - 2025 |
| Spero Therapeutics, Inc. SPRO | Officer | filed 2017 - 2022 |
| VG Acquisition Corp. VGAC.U | Officer | filed 2022 - 2022 |
| Theravance Biopharma, Inc. tbph | Officer | filed 2014 - 2022 |
| Cvrx, Inc. CVRX | Officer | filed 2021 - 2021 |
| Lyell Immunopharma, Inc. LYEL | Officer | filed 2021 - 2021 |
| Theravance INC thrx | Officer | filed 2008 - 2021 |
| Decibel Therapeutics, Inc. [DBTX] | Director | filed 2021 - 2021 |
| Bicycle Therapeutics plc BCYC | Director | filed 2019 - 2020 |
| Genocea Biosciences, INC. GNCA | Officer | filed 2014 - 2020 |
| Pandion Therapeutics, Inc. PAND | Director | filed 2020 - 2020 |
| Nkarta, Inc. NKTX | Director | filed 2020 - 2020 |
| Turning Point Therapeutics, Inc. TPTX | Director | filed 2019 - 2020 |
| Progyny, Inc. PGNY | Officer | filed 2019 - 2020 |
| Orchard Therapeutics plc ORTX | Director | filed 2020 - 2020 |
| Principia Biopharma Inc. PRNB | Officer | filed 2018 - 2019 |
| Fulcrum Therapeutics, Inc. FULC | Officer | filed 2019 - 2019 |
| Morphic Holding, Inc. MORF | Director | filed 2019 - 2019 |
| Chemocentryx, Inc. CCXI | Officer | filed 2012 - 2018 |
| Liquidia Technologies Inc LQDA | Officer | filed 2018 - 2018 |
| Constellation Pharmaceuticals INC CNST | Officer | filed 2018 - 2018 |
| Translate Bio, Inc. TBIO | Officer | filed 2018 - 2018 |
| Rein Therapeutics, Inc. RNTX | Officer | filed 2017 - 2017 |
| HTG Molecular Diagnostics, INC HTGM | Officer | filed 2015 - 2017 |
| Crispr Therapeutics AG CRSP | Officer | filed 2016 - 2016 |
| Applied Genetic Technologies Corp AGTC | Officer | filed 2014 - 2015 |
| Amicus Therapeutics, INC. [FOLD} | Officer | filed 2010 - 2014 |
| Nupathe INC. path | Officer | filed 2014 - 2014 |
| Concert Pharmaceuticals, INC. N/A | Officer | filed 2014 - 2014 |
| Oncomed Pharmaceuticals Inc OMED | Officer | filed 2013 - 2013 |
| Response Genetics INC rgdx | Officer | filed 2012 - 2012 |
| Human Genome Sciences INC HGSI | Director | filed 2012 - 2012 |
| Quest Diagnostics INC dgx | Director | filed 2006 - 2011 |
| Anacor Pharmaceuticals, Inc. ANAC | Officer | filed 2010 - 2010 |
| Robcor Properties Inc RPBC | Officer | filed 2007 - 2010 |
| Maxygen INC MAXY | Officer | filed 2010 - 2010 |
| Epix Pharmaceuticals, Inc. EPIX | Officer | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.